Cargando…
Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body Radiotherapy Using CyberKnife Static Tracking System
PURPOSE: We investigated the dosimetric effect of intrafraction tumor motion in lung stereotactic body radiotherapy using the CyberKnife static tracking system. METHODS: Four-dimensional computed tomography scans of a dynamic thorax phantom were acquired. Two motion ranges, 3 collimator sizes, and 4...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600499/ https://www.ncbi.nlm.nih.gov/pubmed/31248330 http://dx.doi.org/10.1177/1533033819859448 |
_version_ | 1783431130203029504 |
---|---|
author | Chang, Yu Liu, Hong-Yuan Liang, Zhi-Wen Nie, Xin Yang, Jing Liu, Gang Li, Qin Yang, Zhi-Yong |
author_facet | Chang, Yu Liu, Hong-Yuan Liang, Zhi-Wen Nie, Xin Yang, Jing Liu, Gang Li, Qin Yang, Zhi-Yong |
author_sort | Chang, Yu |
collection | PubMed |
description | PURPOSE: We investigated the dosimetric effect of intrafraction tumor motion in lung stereotactic body radiotherapy using the CyberKnife static tracking system. METHODS: Four-dimensional computed tomography scans of a dynamic thorax phantom were acquired. Two motion ranges, 3 collimator sizes, and 4 treatment starting phases were investigated. Monte Carlo dose distributions were calculated on internal target volume with a treatment-specific setup margin for 6 Gy/1 fraction. Dosimetric effects of intrafractional tumor motion were assessed with Gafchromic films. γ (5%/3 mm), dose differences, and distance to agreement were analyzed. RESULTS: With 30 mm collimator plans, the measured dose passed the criteria γ (5%/3 mm) in all tumor motion ranges. The γ passing rates of the plans using 20 mm or 20+35 mm collimators were much lower than that with 30 mm collimator, especially with the 30 mm tumor motion range. The measured dose of 10 mm tumor motion ranges all passed the 90% criteria of γ (5%/3 mm), the results being much better than those of 30 mm tumor motion ranges, which were below 80%. The results of same delivered plan but treated with different starting phases varies greatly. CONCLUSION: Xsight Lung Tracking technique should be used with caution in lung cancer stereotactic body radiation therapy because the temporal dose variations can be significant. |
format | Online Article Text |
id | pubmed-6600499 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-66004992019-07-08 Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body Radiotherapy Using CyberKnife Static Tracking System Chang, Yu Liu, Hong-Yuan Liang, Zhi-Wen Nie, Xin Yang, Jing Liu, Gang Li, Qin Yang, Zhi-Yong Technol Cancer Res Treat Original Article PURPOSE: We investigated the dosimetric effect of intrafraction tumor motion in lung stereotactic body radiotherapy using the CyberKnife static tracking system. METHODS: Four-dimensional computed tomography scans of a dynamic thorax phantom were acquired. Two motion ranges, 3 collimator sizes, and 4 treatment starting phases were investigated. Monte Carlo dose distributions were calculated on internal target volume with a treatment-specific setup margin for 6 Gy/1 fraction. Dosimetric effects of intrafractional tumor motion were assessed with Gafchromic films. γ (5%/3 mm), dose differences, and distance to agreement were analyzed. RESULTS: With 30 mm collimator plans, the measured dose passed the criteria γ (5%/3 mm) in all tumor motion ranges. The γ passing rates of the plans using 20 mm or 20+35 mm collimators were much lower than that with 30 mm collimator, especially with the 30 mm tumor motion range. The measured dose of 10 mm tumor motion ranges all passed the 90% criteria of γ (5%/3 mm), the results being much better than those of 30 mm tumor motion ranges, which were below 80%. The results of same delivered plan but treated with different starting phases varies greatly. CONCLUSION: Xsight Lung Tracking technique should be used with caution in lung cancer stereotactic body radiation therapy because the temporal dose variations can be significant. SAGE Publications 2019-06-27 /pmc/articles/PMC6600499/ /pubmed/31248330 http://dx.doi.org/10.1177/1533033819859448 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Chang, Yu Liu, Hong-Yuan Liang, Zhi-Wen Nie, Xin Yang, Jing Liu, Gang Li, Qin Yang, Zhi-Yong Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body Radiotherapy Using CyberKnife Static Tracking System |
title | Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body
Radiotherapy Using CyberKnife Static Tracking System |
title_full | Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body
Radiotherapy Using CyberKnife Static Tracking System |
title_fullStr | Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body
Radiotherapy Using CyberKnife Static Tracking System |
title_full_unstemmed | Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body
Radiotherapy Using CyberKnife Static Tracking System |
title_short | Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body
Radiotherapy Using CyberKnife Static Tracking System |
title_sort | dosimetric effect of intrafraction tumor motion in lung stereotactic body
radiotherapy using cyberknife static tracking system |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600499/ https://www.ncbi.nlm.nih.gov/pubmed/31248330 http://dx.doi.org/10.1177/1533033819859448 |
work_keys_str_mv | AT changyu dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem AT liuhongyuan dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem AT liangzhiwen dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem AT niexin dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem AT yangjing dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem AT liugang dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem AT liqin dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem AT yangzhiyong dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem |